Financing channel feed – Endpoints News

Financing channel feed

Funding for biotech startups had its best quarter in two years — sort of

10 months ago

Novo-partnered 3D bioprinting biotech gets $70M+ from Canadian government

10 months ago

Flagship's Noubar Afeyan on uncertainty, AI and biotech’s future

10 months ago

Updated: Flagship reels in $3.6B to create 25 new companies

10 months ago

Biovance debuts with €51M to lift up biotech scene in Portugal and southern Europe

10 months ago

German antibody company secures €63M for autoimmune disease program

10 months ago

Digital health deals rallied in the first half of 2024, though funding still trails last year

10 months ago

Exclusive: Gene insertion startup launches with new integrase technology from University of Hawaii

10 months ago

With cash expected to run dry, Inventiva ramps up search for funding

10 months ago

VC firm emerges to boost Austrian biotech scene that’s ‘ready to break out’

10 months ago

In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly's support

10 months ago

Circle Pharma raises $54M as part of Series D while macrocycles heat up

10 months ago

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

10 months ago

Flagship appears to boost target of eighth fund by up to $500M

10 months ago

Beacon raises $170M to take on J&J in ocular gene therapy

10 months ago

Cartesian clears an autoimmune CAR-T trial, starts another Phase 2 and raises $130M

10 months ago

Seeking 'financial flexibility,' Esperion sells European royalty on cholesterol-lowering drugs

10 months ago

Artiva refiles for IPO three years after original plans in a vastly different environment

10 months ago

Immunology biotech Alumis secures $250M in shrunken IPO

10 months ago

One Medical CEO-turned-VC wants startups that are 'disruptive from within the ecosystem'

10 months ago

Exclusive: To develop better cell therapies for solid tumors, a new startup plans to test hundreds of them at once

10 months ago

Longevity investors look to add $200M to the table with new growth fund

10 months ago

With a $372M megaround, Formation Bio looks to in-license 10+ drugs

10 months ago

Alexis Borisy and Zach Weinberg's Curie.Bio secures $380M to support portfolio's Series A rounds

10 months ago

First page Previous page 11 12 131415 16 17 Next page Last page